This course was last updated on
April 24, 2017
CME credit has expired.


Ruben A. Mesa, MD, provides practical insights into treating polycythemia vera in this video series. In addition to discussing risk stratification, Dr. Mesa uses case scenarios to illustrate how treatment strategies can be selected and modified to meet individual needs.

Content Areas

  • Epidemiology
  • Risk-based treatment selection
  • Addressing treatment intolerance and resistance
  • Current and emerging therapies

Target Audience

This activity was developed for hematologist-oncologists, hematologists, oncologists, and other healthcare professionals who have an interest in polycythemia vera.

This activity is supported by an independent educational grant from Incyte Corporation.


Ruben A. Mesa, MD
Ruben A. Mesa, MD
Professor of Medicine
Consultant Hematologist
Chair, Division of Hematology & Medical Oncology
Deputy Director, Mayo Clinic Cancer Center
Mayo Clinic in Arizona
Phoenix, Arizona
Enter your information to begin.
CME Credit
Available Credit: 1.00 AMA PRA Category 1 Credit™.
Opens: April 24, 2017
Expires: April 23, 2018
Target Audience: Hematologist/Oncologists
Other Healthcare Providers